Skip to content

Clinical Trial of Phosphorylated Tau 217 Protein (p-Tau 217) Detection Kit (Flow Fluorescent Assay) and Its Supporting Flow Fluorescence Data Analysis Software

Clinical Trial of Phosphorylated Tau 217 Protein (p-Tau 217) Detection Kit (Flow Fluorescent Assay) and Its Supporting Flow Fluorescence Data Analysis Software

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600127055
Enrollment
Unknown
Registered
2026-06-23
Start date
2026-07-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer’s Disease

Interventions

Observation group:N/A

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Subjects diagnosed with Alzheimer’s disease, mild cognitive impairment with pathological changes of Alzheimer’s disease, or subjective cognitive decline; or those presenting with suspected Alzheimer’s disease-related symptoms including memory loss, behavioral and psychological changes, cognitive impairment, etc.; or patients with other related diseases such as Parkinson’s disease, vascular dementia, dementia with Lewy bodies, frontotemporal dementia and other similar conditions. 2. The subject or their legal guardian has voluntarily signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Samples with insufficient volume for trial testing. 2. Samples not collected or processed in accordance with requirements. 3. Contaminated samples. 4. Other circumstances deemed ineligible for this trial by the investigator.

Design outcomes

Primary

MeasureTime frame
Sensitivity;Specificity;

Countries

China

Contacts

Public ContactGuo Qihao

Shanghai Sixth People's Hospital

Dr.guoqihao@126.com+86 138 1774 1448

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 3, 2026